Latest Bisphosphonate Stories
CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties.
EAST HANOVER, N.J., June 5 /PRNewswire/ -- New data to be presented tomorrow at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, show that the addition of ZometaÂ® (zoledronic acid) to first-line chemotherapy significantly improved overall survival for newly diagnosed multiple myeloma patients by 16% (P=0.0118) and progression-free survival by 12% (P=0.0179) compared with oral clodronate plus first-line chemotherapy(1).
CHICAGO, May 26 /PRNewswire-USNewswire/ -- People undergoing bisphosphonate therapy to prevent or treat osteoporosis (a thinning of the bones) may be unfamiliar with the drug and possible adverse side effects on oral health, according to a study in the May issue of The Journal of the American Dental Association (JADA). Use of bisphosphonates has been associated with a small risk of developing bisphosphonate-associated osteonecrosis of the jaw (BON) that occurs spontaneously or after the...
Studies find possible links between prolonged bisphosphonate treatments.
Studies find possible links between prolonged bisphosphonate treatments and atypical fractures in post-menopausal women NEW ORLEANS, March 10 /PRNewswire-USNewswire/ -- Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American...
SEATTLE, March 5 /PRNewswire/ -- Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S.
Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S. researchers published today in the British Journal of Cancer.
A University of Cambridge study suggests that women who have suffered a bone fracture are not receiving treatment to protect against future breaks.
A team of Israeli researchers say they have developed a new drug carrier to deliver compounds straight to a tumor to starve it of blood. Dr.
THOUSAND OAKS, Calif., Sept.
- A poem in which the author retracts something said in an earlier poem.